The orphan-drug exemption could incentivize a large pharma company without qualifying drugs to acquire a biotech company holding two or more orphan drugs in order to escape IRA price controls on those specific drugs.
forecastpending
Speaker
Steve EismanEvidence Quote
“could this cause me to go buy some biotech company that has two orphan drugs?”
Source
Big Beautiful Bill, Write-Off Revolution & Tariff Tempest — The Friday Market Wrap!— Steve EismanCreated: 6/18/2026, 2:31:55 PM
My Notes
Loading notes...